Cite Filings / HALO / 0001140361-19-019841
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

HALOZYME THERAPEUTICS, INC. · Filed 2019-11-05 · Acc 0001140361-19-019841

Documents 1

  • SC 13D/A Beneficial Ownership Report , formsc13da.htm

Around this filing

  • 2019-11-12 8-K Other events
  • 2019-11-12 8-K/A Exit or restructuring costs · Impairment
  • 2019-11-12 10-Q Quarterly Report
  • 2019-11-12 8-K Results of operations
  • 2019-11-05 8-K Exit or restructuring costs · Impairment · Executive or director change
  • 2019-11-05 SC 13D/A Beneficial Ownership Report
  • 2019-07-03 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2021-02-12 SC 13G/A · BB Biotech AG 2.9%
  2. 2020-02-14 SC 13G/A · BB Biotech AG 5.4%
  3. 2019-02-13 SC 13G/A · BB Biotech AG 5.8%
  4. 2018-02-14 SC 13G/A · BB Biotech AG 6.0%
  5. 2017-02-14 SC 13G/A · BB Biotech AG 5.9%
  6. 2016-02-09 SC 13G/A · BB Biotech AG 5.5%
  7. 2015-02-13 SC 13G/A · BB Biotech AG 5.4%
  8. 2014-08-07 SC 13G · BB Biotech AG 5.0%
  9. 2014-02-12 SC 13G/A · BB Biotech AG 4.1%
  10. 2013-08-14 SC 13G · BB Biotech AG 5.1%
Loading formsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…